In multivariable analysis of DDFS, PAR-2 was an independent prognostic factor in the ER-positive group (HR: 3.9, 95% CI: 1.03–15.0, P = 0.045) when adjusting for age, tumor size, grade, Ki-67and HER-2 status. This evidence concerns the gene ERBB2 and neoplasm.